Newsletters
ePaper
Sign in
Home
India
Assembly Polls 2024
Karnataka
Opinion
World
Business
Sports
Entertainment
Video
News Shots
Explainers
Bengaluru
Science
Trending
Photos
Brandspot
DH Specials
Home
News Shots
Trending
Menu
×
ADVERTISEMENT
ADVERTISEMENT
GSK
GSK's experimental drug shows promise in reducing severe asthma attacks
The results come as GSK sharpens focus on its respiratory health portfolio, which is currently thriving on the back of back of a strong launch of its respiratory syncytial virus (RSV) vaccine Arexvy.
21 May 2024, 07:37 IST
GSK's experimental drug shows promise in reducing severe asthma attacks
21 May 2024, 07:37 IST
European Commission authorises GSK's HIV prevention drug
Cabotegravir is recommended in combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually-acquired HIV-1 infection.
19 September 2023, 08:05 IST
European Commission authorises GSK's HIV prevention drug
19 September 2023, 08:05 IST
US FDA approves GSK's bone marrow cancer therapy
The approval comes after the health regulator in July delayed its decision to review additional data.
16 September 2023, 13:38 IST
US FDA approves GSK's bone marrow cancer therapy
16 September 2023, 13:38 IST
GSK reports Q4 profit, sales beat Wall Street estimates
Analysts were expecting 21.2 pence per share on sales of about 7.1 billion pounds, company-compiled consensus estimates showed
01 February 2023, 12:34 IST
GSK reports Q4 profit, sales beat Wall Street estimates
01 February 2023, 12:34 IST
Drugmaker GSK profit rockets on consumer health spinoff
Earnings after taxation spiked in the three months to the end of September
02 November 2022, 09:36 IST
Drugmaker GSK profit rockets on consumer health spinoff
02 November 2022, 09:36 IST
GSK spin-off to create consumer healthcare giant
The demerging has caused the largest stock market listing in more than a decade
16 July 2022, 04:37 IST
GSK spin-off to create consumer healthcare giant
16 July 2022, 04:37 IST
Why world's first malaria shot won't reach millions
GSK committed to produce up to 15 million doses every year through 2028 - considerably less than the WHO says is needed
13 July 2022, 11:14 IST
Why world's first malaria shot won't reach millions
13 July 2022, 11:14 IST
Pfizer to exit GSK's consumer health arm after spin-off
GSK said on Wednesday that Pfizer would exit its investment in a 'disciplined manner'
01 June 2022, 09:01 IST
Pfizer to exit GSK's consumer health arm after spin-off
01 June 2022, 09:01 IST
Britain's GSK buys Affinivax in $3.3-billion deal
The London-listed company has agreed to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones for Affinivax
31 May 2022, 10:26 IST
Britain's GSK buys Affinivax in $3.3-billion deal
31 May 2022, 10:26 IST
GSK tops quarterly forecasts, helped by Covid treatment
Turnover in the three months to March 31 was boosted by $1.64 billion in sales from its Covid-19 antibody treatment, Xevudy
27 April 2022, 09:10 IST
GSK tops quarterly forecasts, helped by Covid treatment
27 April 2022, 09:10 IST
<
1
2
...
5
>
